Dose-finding Study to Evaluate Immunogenicity of Three Different Dose Levels of the IMVAMUNE (MVA-BN) Smallpox Vaccine.
Condition:   SmallpoxIntervention:   Biological: IMVAMUNE (MVA-BN)Sponsors:   Bavarian Nordic;   National Institute of Allergy and Infectious Diseases (NIAID)Completed - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 11, 2005 Category: Research Source Type: clinical trials

Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in Patients With Atopic Disorders
Conditions:   Dermatitis, Atopic;   Hay FeverIntervention:   Biological: IMVAMUNE (MVA-BN)Sponsors:   Bavarian Nordic;   National Institute of Allergy and Infectious Diseases (NIAID)Completed - verified June 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 11, 2005 Category: Research Source Type: clinical trials

Dose-finding Study to Evaluate Immunogenicity of Three Different Dose Levels of the IMVAMUNE (MVA-BN) Smallpox Vaccine.
Condition:   SmallpoxIntervention:   Biological: IMVAMUNE (MVA-BN)Sponsors:   Bavarian Nordic;   National Institute of Allergy and Infectious Diseases (NIAID)Completed - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 11, 2005 Category: Research Source Type: clinical trials

VHA Clinicians and Bioterror Events: Interactive Web-based Learning
Conditions:   Smallpox;   AnthraxIntervention:   Behavioral: BioCASES and BioTESTSSponsors:   Department of Veterans Affairs;   University of Alabama at BirminghamCompleted - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2005 Category: Research Source Type: clinical trials